Literature DB >> 15607797

NK cell regulation of T cell-mediated responses.

Alessandra Zingoni1, Thierry Sornasse, Benjamin G Cocks, Yuetsu Tanaka, Angela Santoni, Lewis L Lanier.   

Abstract

NK cells promote adaptive immune responses through their production of type 1 and type 2 cytokines or chemokines. Secretion of these factors by activated NK cells influences the differentiation of B and T lymphocytes. Increasing evidence indicates that NK cells are also directly involved in dendritic cell (DC) maturation. By contrast, a potential role for direct cell-cell interactions between NK and T lymphocytes, in particular CD4(+) T cells, has not been explored. We provide evidence that activated human NK cells are able of promoting TcR-dependent proliferation of resting autologous peripheral blood CD4(+) T cells by a process that involves costimulatory molecules of the immunoglobulin (Ig) and tumor necrosis factor (TNF) superfamilies. These findings suggest a novel link between natural and adaptative immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15607797     DOI: 10.1016/j.molimm.2004.07.025

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  27 in total

Review 1.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

Review 2.  Biocompatibility of implants: lymphocyte/macrophage interactions.

Authors:  James M Anderson; Amy K McNally
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

Review 3.  Evolving immune circuits are generated by flexible, motile, and sequential immunological synapses.

Authors:  Audrey Gérard; Peter Beemiller; Rachel S Friedman; Jordan Jacobelli; Matthew F Krummel
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

Review 4.  Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.

Authors:  Andrea Loewendorf; Marie Csete
Journal:  Stem Cells Transl Med       Date:  2013-01-24       Impact factor: 6.940

Review 5.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

6.  THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Authors:  Nicole A Dobbs; Adam N Odeh; Xiangle Sun; Jerry W Simecka
Journal:  Curr Trends Immunol       Date:  2009

7.  Natural killer cells control a T-helper 1 response in patients with Behçet's disease.

Authors:  Yukie Yamaguchi; Hayato Takahashi; Takashi Satoh; Yuka Okazaki; Nobuhisa Mizuki; Kazuo Takahashi; Zenro Ikezawa; Masataka Kuwana
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

8.  NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization.

Authors:  Sheetal Bodhankar; Mathew D Woolard; Xiangle Sun; Jerry W Simecka
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

9.  A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection.

Authors:  Megan M Crumpler; K Yeon Choi; Michael A McVoy; Mark R Schleiss
Journal:  Vaccine       Date:  2009-05-03       Impact factor: 3.641

10.  Natural killer cells in perinatally HIV-1-infected children exhibit less degranulation compared to HIV-1-exposed uninfected children and their expression of KIR2DL3, NKG2C, and NKp46 correlates with disease severity.

Authors:  Wassim M Ballan; Bien-Aimee N Vu; Brian R Long; Christopher P Loo; Jakob Michaëlsson; Jason D Barbour; Lewis L Lanier; Andrew A Wiznia; Jacobo Abadi; Glenn J Fennelly; Michael G Rosenberg; Douglas F Nixon
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.